Company intelligence / Profile preview

Beijing Jayyalife Biological Technology

Beijing, Beijing, Chinajayyalife.com.cn ↗

Ownership: Private
Development stage: Other

Overview

Beijing Jayyalife Biological Technology is recognized as one of the leading global manufacturers of anal fistula patches, with its products commercially available and contributing significantly to this niche market segment. The company utilizes decellularized vascular matrix technology in its flagship product, which is designed for improved healing in patients with anal fistulas. No clinical trial data or broader clinical pipeline information was found.

Therapeutic areas: Gastroenterology
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Beijing Jayyalife Biological Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Jayyalife Biological Technology.

Explore the full profile